Catheter-associated bloodstream infection after bowel surgery in patients with inflammatory bowel disease

Uchino, Motoi; Ikeuchi, Hiroki; Matsuoka, Hiroki; Bando, Toshihiro; Ichiki, Kaoru; Nakajima, Kazuhiko; Takahashi, Yoshiko; Tomita, Naohiro; Takesue, Yoshio
April 2014
Surgery Today;Apr2014, Vol. 44 Issue 4, p677
Academic Journal
Purpose: Catheter-associated bloodstream infections (CABSIs) are a leading cause of nosocomial infections. The objectives of this study were to establish the incidence of CABSIs after bowel surgery and to identify the risk factors. Methods: We reviewed the prospectively collected data of patients who underwent abdominal surgery with central venous catheter (CVC) insertion between March, 2006 and September, 2009. We analyzed all possible variables, including age, sex, disease, CVC duration, insertion frequency, CVC site, infliximab, corticosteroid, and immunosuppressant administration, preoperative serum albumin level, surgical wound class, and emergency surgery. Results: A total of 1261 patients were prospectively surveyed. The underlying diseases comprised ulcerative colitis (UC; n = 428), Crohn's disease (CD; n = 334), colorectal cancer (CA; n = 344), esophageal cancer (ESO; n = 28), gastric cancer (GAST; n = 44), and others ( n = 83). The incidences of CABSI were 6.9/1000 catheter days for UC, 7.4 for CD, 4.3 for CA, 3.7 for ESO, 3.7 for GAST, and 5.1 for others. CD patients had the highest rate of CABSI. The risk factors for CABSI were CD with an odds ratio (OR) of 1.63, dirty/infected wound class (OR 3.34), and CVC insertion via the internal jugular vein (OR 9.89). Conclusion: A high CABSI incidence was found in association with CD, especially in dirty/infected surgery. Thus, the use of CVCs should be restricted in the presence of these risk factors.


Related Articles

  • Lessons to Learn from Crohn's Disease Clinical Trials: Implications for Ulcerative Colitis. Jáuregui-Amézaga, Aránzazu; Ricart, Elena; Panés, Julián // Current Drug Targets;Sep2011, Vol. 12 Issue 10, p1467 

    The perception that Crohn's disease is a more severe process than ulcerative colitis, led to the initial development of a majority drugs, and testing of treatment strategies, in the former. In the absence of similar studies in ulcerative colitis, information of Crohn's disease studies may help...

  • Where the Rubber Meets the Road. WEINER, GARY // Naturopathic Doctor News & Review;Jan2014, Vol. 10 Issue 1, p1 

    The article focuses on treatment of inflammatory bowel disease (IBD), one of the five most prevalent gastrointestinal diseases in the U.S. IBD is comprised of ulcerative colitis (UC) and Crohn's disease (CD). It states that IBD is without a medical cure and often requires a lifetime of care. The...

  • Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Charpentier, Cloé; Salleron, Julia; Savoye, Guillaume; Fumery, Mathurin; Merle, Véronique; Laberenne, Jean-Eric; Vasseur, Francis; Dupas, Jean-Louis; Cortot, Antoine; Dauchet, Luc; Peyrin-Biroulet, Laurent; Lerebours, Eric; Colombe, Jean-Frédéric; Gower-Rousseau, Corinne // Gut;Mar2014, Vol. 63 Issue 3, p423 

    Data on the natural history of elderly-onset inflammatory bowel disease (IBD) are scarce. Methods In a French population-based cohort we identified 841 IBD patients >60 years of age at diagnosis from 1988 to 2006, including 367 Crohn's disease (CD) and 472 ulcerative colitis (UC). Results Median...

  • Flare-up of ulcerative colitis after systemic corticosteroids: A strong case for Strongyloides. Shomron Ben-Horin; Barshack, Iris; Chowers, Yehuda; Mouallem, Meir // World Journal of Gastroenterology;7/21/2008, Vol. 14 Issue 27, p4413 

    Super-imposed infection with intestinal organisms can mimic a flare-up of underlying disease in patients with inflammatory bowel disease (IBD). We report a case of patient with long standing ulcerative colitis (UC), who presented with abdominal pain, diarrhea and low-grade fever after receiving...

  • Acute Severe Colitis: Infliximab and/or Cyclosporine? Fabro, Mauro; Szabo, Hajnalka; Terrosu, Giovanni; Avellini, Claudio; Tabuso, Maria; Fiorino, Gionata; Sorrentino, Dario // Current Drug Targets;Sep2011, Vol. 12 Issue 10, p1448 

    Acute severe ulcerative colitis is a serious condition that requires early hospitalization, with intensive monitoring and treatment. Despite the recent progress in the medical approach of Inflammatory Bowel Diseases acute severe ulcerative colitis remains a clinical challenge, with a mortality...

  • Steroid-Refractory Severe Ulcerative Colitis. Moss, Alan C.; Peppercorn, Mark A. // Drugs;2008, Vol. 68 Issue 9, p1157 

    Approximately 15% of patients with ulcerative colitis will experience a severe episode requiring hospitalization. Although intravenous corticosteroids are the current first-line therapy for these patients, about 30% of patients do not respond to corticosteroids and require either an alternative...

  • AGA Reviews the Use of Corticosteroids, Immunomodulators, and Infliximab in IBD. Graham, Lisa // American Family Physician;2/1/2007, Vol. 75 Issue 3, p410 

    The article focuses on the guidance issued by the American Gastroenterological Association (AGA) on the use of corticosteroids, immunomodulators and infliximab in the treatment of inflammatory bowel disease (IBD). Budesonide can be given to patients with mild to moderate IBD but should not be...

  • Medical Management of Ulcerative Colitis with a Specific Focus on 5-Aminosalicylates. Freeman, Hugh James // Clinical Medicine Insights: Gastroenterology;2012, Issue 5, p77 

    Medical management of ulcerative colitis has continued to evolve over more than half of a century. Perhaps, the important advance was the development of sulfasalazine, a drug initially used for the treatment of inflammatory joint disease and only later in the treatment of inflammatory bowel...

  • Pharmacogenetics and Inflammatory Bowel Disease. Phillips, A. M.; Hare, N.C.; Satsangi, J. // Current Pharmacogenomics & Personalized Medicine;2008, Vol. 6 Issue 3, p201 

    The inflammatory bowel diseases, Crohn's disease and ulcerative colitis, are common causes of significant morbidity, especially in young people. Current knowledge of aetiology is incomplete, but increasingly the evidence points towards a combination of appropriate environmental triggers in a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics